Boyin Liu

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Polymyxin is the last-line therapy against Gram-negative 'superbugs'; however, dose-limiting nephrotoxicity can occur in up to 60% of patients after intravenous administration. Understanding the accumulation and concentration of polymyxin within renal tubular cells is essential for the development of novel strategies to ameliorate its nephrotoxicity and to(More)
  • 1